Najlepsze podcasty z kategorii: MTech (2024)

1
How does funding flow in NHSE Regions? 1:00:15

25d ago1:00:15

1:00:15

Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with Region leaders? We sit down with guest speaker Richard Smale (Interim Director of System Co-ordination, NHS England [NHSE] – South West) for an all-encompassing discussion that explored fi…

1
NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024) 1:02:06

25d ago1:02:06

1:02:06

What do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a general election and a potential Labour government on the horizon, how can NHS and industry drive forward improvements and innovation? Host Robert Hull (Senior Consultant – NHS Insight & Interaction, Mte…

1
De-mystifying health economic model classifications and structures 1:00:28

1M ago1:00:28

1:00:28

What is health economic evaluation and which modelling approaches can be used to support market access activities? In this episode, our expert health economists explain the key strengths and limitations of the most common health economic modelling classifications and structures. Here, Hannah Gillies (Consultant – Health Economics) and Daniel MacDon…

1
Evidence strategy for Medical Technologies and Diagnostics 53:24

2M ago53:24

53:24

Here, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies. Have you established the clinical and economic value of your medical device, diagnostic or digital technology? Do you have the evidence required to support your value proposition? Would a health technology assessment (HTA) route be approp…

1
How to set your Pharma or Medtech product up for success in the US market 43:06

2M ago43:06

43:06

How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice commercialisation strategy for healthcare products launching in the US market. Clare Foy (Director – Global Market Access, Mtech Access) speaks to Janice MacLennan (…

1
What's happening with specialised commissioning in the NHS? 1:00:08

3M ago1:00:08

1:00:08

What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty? Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to expl…

1
Integrated care in NHS Wales – what can England learn from its neighbour? 56:24

4M ago56:24

56:24

What does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England? Paul Mears (CEO, Cwm Taf Morgannwg University Health Board) joins Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) to explore the integrated care model in Wales and th…

1
Market access in Italy: Reforms at AIFA 43:36

5M ago43:36

43:36

Clare Foy (Director – Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer) about the market access landscape in Italy, particularly regarding changes at the Agenzia Italiana del Farmaco (AIFA). We explore: - The nature of the Ita…

1
Unmet need in NHS primary care – How can industry best support PCN leaders? 1:00:44

5M ago1:00:44

1:00:44

Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how industry can best support primary care leaders and GPs as we head into winter, 2024 and beyond. Former ‘GP of the year’ and strategic influencer over prim…

1
Population health management: a community effort across health and life sciences 1:04:01

6M ago1:04:01

1:04:01

How can our community support NHS leaders to deliver a data-led, people-centric health service? Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) to explore the power of data, the role of community and how the health and life sciences ecosystem can support the NHS’s popu…

1
Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access 39:54

6M ago39:54

39:54

How is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean for the future of market access? In this webinar, Dr George Magrath explains how his team at Lexitas are using AI in clinical trials in the field of op…

1
6 areas of UK health policy for Medtech to pay attention to 1:01:49

7M ago1:01:49

1:01:49

How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators? Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) speaks to William Lee (Head of Policy and Compliance, British Healthcare Trades Association [BHTA]) about health policy, regulation and its implications for…

1
Market access in the German speaking markets 57:59

8M ago57:59

57:59

Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets. Clare and Stefan discuss: …

1
The role of nursing in driving digital change in the NHS 54:50

9M ago54:50

54:50

How are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinical teams to support improved patient care? And how can Medtech, Digital and Biotech innovators collaborate with the front-line nursing teams in the NHS to drive transformation? Prof. Phil Richardson (Chair and C…

1
Market access for digital therapies and digital medicines 42:18

10M ago42:18

42:18

In this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcome…

1
A global market access journey in cannabinoid pharmaceuticals 53:47

11M ago53:47

53:47

What does it take to bring a cannabinoid pharmaceutical to market? We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceuticals) as the first guest on our new Global Whispers webinar series. Michael shared with us his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons …

1
Primary Care and ICBs – what is the next step in the integration journey? 1:01:17

12M ago1:01:17

1:01:17

How will changes to the structure of primary care impact decision making? How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows be impacted? Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Tim Goodson (Executive Officer, Dorset General Pract…

1
(ChatGPT) - اپیزود ۱۶ - هوش مصنوعی و چت جی پی تی . ترفند های تغذیه و سلامتی روده 34:27

12M ago34:27

34:27

.اگر از اپیزود خوشتون اومده با ما در ارتباط باشین و ایمیل بزنین Email : mtechpodcast@gmail.com تبلیغ و اسپانسر نداریم و علاقمون، یادگیری و اضافه کردن ارزش به شما, بهمون انرژی میده. پس دنبالمون کنید، ایمیل بزنید و ما رو به دوستاتون معرفی کنید. Email : ⁠mtechpodcast@gmail.com

1
Data-led transformation in the NHS - partnering to optimise patient care 1:02:35

1y ago1:02:35

1:02:35

Is data the key to transforming healthcare systems and patient care? What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner with the NHS to share data, transform services, and find smarter, faster way to improve patient care? Prof. Phil Richardson (Chair and Chief Innovation Officer, …

1
Innovating for better health – research, collaboration and innovation in the NHS 57:56

1y ago57:56

57:56

How and where can innovation drive improvements in care and deliver better health for the population? How is the NHS looking to collaborate with key partners across industry and academia? What innovations are set to transform care? What role do Academic Health Science Networks (AHSNs) play and how can partners best engage with them? Prof Phil Richa…

1
اپیزود پانزدهم - اعتماد به نفس - ۴ قدم مهم برای ساختن اعتماد به نفس 29:40

1y ago29:40

29:40

.اگر از اپیزود خوشتون اومده با ما در ارتباط باشین و ایمیل بزنین Email : mtechpodcast@gmail.com تبلیغ و اسپانسر نداریم و علاقمون، یادگیری و اضافه کردن ارزش به شما بهمون انرژی میده، پس دنبالمون کنید، ایمیل بزنید و ما رو به دوستاتون معرفی کنید.

1
اپیزود چهاردهم - ۲۶ عادت برای افزایش تمرکز 26:58

1+ y ago26:58

26:58

.اگر از اپیزود خوشتون اومده با ما در ارتباط باشین و ایمیل بزنین Email : mtechpodcast@gmail.com تبلیغ و اسپانسر نداریم و علاقمون، یادگیری و اضافه کردن ارزش به شما بهمون انرژی میده، پس دنبالمون کنید، ایمیل بزنید و ما رو به دوستاتون معرفی کنید.

1
Healthcare, economics and society – unlocking NHS collaboration 59:23

1+ y ago59:23

59:23

Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change? What social and economic value do ICSs offer the wider population they serve? How will industry support ICSs to deliver population-based health and social benefits? Prof Phil Richardson (Chair and Chief Innovation Officer, Mte…

1
Specialised Commissioning in the NHS – What do you need to know now 1:00:34

1+ y ago1:00:34

1:00:34

The proposed new NHSE systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects or policy have been published in ways that are hard to access and even harder to interpret. Here, we gather an expert panel to discuss what proposed new NHSE systems for specialised commi…

1
اپیزود سیزدهم - چطوری تو موقعیت های اجتماعی اضطراب کمتری داشته باشیم 11:48

1+ y ago11:48

11:48

.اگر از اپیزود خوشتون اومده با ما در ارتباط باشین و ایمیل بزنین Email : mtechpodcast@gmail.com تبلیغ و اسپانسر نداریم و علاقمون، یادگیری و اضافه کردن ارزش به شما بهمون انرژی میده، پس دنبالمون کنید، ایمیل بزنید و ما رو به دوستاتون معرفی کنید. دوستون داریم

1
اپیزود ۱۲ - سه قدم تا خلاقیت 20:17

1+ y ago20:17

20:17

تقدیم به مردم عزیز بلوچ سرزمینمون ایران

1
Why are we waiting? - Pressures facing the NHS and how to deliver change 1:00:47

1+ y ago1:00:47

1:00:47

With so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can industry work with the NHS to improve patient flow to get people appropriate treatment sooner and limit the harm caused by waiting? Prof Phil Richardson (new Chief Innovat…

1
اپیزود یازدهم - ابزار های تکنولوژی برای مدیریت زندگی / دایره طلایی از سایمون سینک 54:54

1+ y ago54:54

54:54

تقدیم به نیکا شاکرمی و تمام مردم آزادی خواه ایران زن زندگی آزادی

1
Priority setting in primary care - NHS insights 59:35

1+ y ago59:35

59:35

How is the NHS balancing competing challenges as we head through integration and towards winter? How are priorities set and what does system planning look like in primary care? Dr Alex Degan (Primary Care Medical Director, Devon Integrated Care System [ICS]) joins Tom Clarke (Director, Mtech Access) to explore all this and more. In this episode, we…

1
اپیزود دهم -- چرا و چجوری با تکنولوژی سالم زندگی کنیم؟ / چگونه سیستم ایمنی بدن را در برابر ویروس کرونا بسازیم؟ 59:13

1+ y ago59:13

59:13

...این اپیزود تقدیم به مهسا امینی و زنده نگه داشتن هرچه بیشتر یادش Mahsa Amini, RIP...

1
لینکدین چیه؟ / چجوری هزار دلار درامد آنلاین داشته باشیم؟ 44:42

1+ y ago44:42

44:42

تو قسمت تکنولوژی، امیر واسمون از لینکدین میگه و اینکه چجوری کار میکنه، به چه دردی میخوره علی تو قسمت موفقیت یک راه نسبتا ساده رو معرفی میکنه که باهاش میشه درامد آنلاین ساخت و اصطلاحا آب باریکه ای درست کنیم که بتونه خیلی جاها تو زندگی کمک خرجمون باشه تو چالش ها و لحظه های خوب. بهمون ایمیل بزنین یا پیام بدید تا بهمون حس شنیده شدن و انگیزه بیشتر واسه …

1
Integrated Care Systems go live in the NHS - reflections after 3 weeks 1:00:21

1+ y ago1:00:21

1:00:21

On 1st July we saw the introduction of legislation for Integrated Care Systems (ICSs) in the NHS. In the weeks since, what has changed for healthcare leaders, practitioners and patients? What are the key priorities for NHS decision-makers and what is getting in the way of change? How can Pharma and Medtech support their NHS customers as they implem…

1
Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role 1:00:46

2y ago1:00:46

1:00:46

What roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how can industry best support these new decision-makers? Tom Clarke (Director, Mtech Access) explores all this and more with Tom Kallis (Senior Clinical Pharmacist, East Cornwall PCN). They explore the origins of the …

1
اپیزود هشتم: نوع جدید هدف گذاری / اپلیکیشن های آموزش زبان Babbel, Italki, Memrise 47:25

2y ago47:25

47:25

تو قسمت موفقیت این هفته، علی از در مورد یک نوع جدید و‌خلاقانه هدف گذاری صحبت میکنه که بر اساس دو اصل مهم هست به اسم لذت و کنترل.یعنی وقتی هدف گذاری میکنیم، اول این سوال رو از خودمون بپرسیم که به جای این که تمرکز کنیم روی یک مقصد مشخص، چطوری میتونیم از مسیر لذت ببریم؟و سوال دوم اینه که چجوری این مسیر میتونه کاملا تو کنترل خودمون باشه، و‌‌ چرا بهتره …

1
اپیزود هفتم : دستیار رایتینگ گرامارلی (Grammarly) چیست ؟ لایف استایل زندگی فصلی (seasonality of life) 45:37

2y ago45:37

45:37

تو اینترو توضیح میدیم که چجوری با رسیدن به اپیزود هفت، وارد ۳۰٪ بالای پادکستای دنیا شدیم. تو قسمت موفقیت علی برامون یک لایف استایل خوشگل معرفی میکنه برای هماهنگ تر زندگی کردن با طبیعت. هماهنگ زندگی کردن با طبیعت یعنی تو هر فصل سال ما سبک زندگی و تم و اولویت هامون عوض میشه. تو زمستون بهتر رو یادگیری تمركز کنیم، بهار فصل تجربه های جديد و‌صحیح و خطاست…

1
Transforming systems and care pathways for an integrated NHS 1:00:47

2y ago1:00:47

1:00:47

As the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, and what does this look like in reality for local systems and populations? Tom Clarke (Director, Mtech Access) explores all this and more with Debbie Morgan, (Director of Service Improvement and Transformation, C…

1
دستیار رایتینگ کویل بات (QuillBot) چیست ؟ مهم ترین مهارت اجتماعی (قسمت سوم) 37:18

2y ago37:18

37:18

تو این اپیزود در مورد قسمت سوم مهارت های اجتماعی صحبت میکنیم که چطوری با یک تکنیک به ایم بیپ-بیپ، ما میتونیم مکالمه رو به مسیری هدایت کنیم که دو طرف مکالمه لذت ببرن از ارتباط،تو قسمت تکنولوژی ،امیر واسامون از یک ابزار رایتینگ‌‌میگه به اسمکویل بات،که کمک میکنه متن های انگلیسیمون رو دوباره نویسی کنیم تا درگیر مسائلی مثل کپی رایت نشیم و همچنین تو بهتر…

1
Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers 39:25

2y ago39:25

39:25

Our experts in health economics, value communication, design and digital discuss how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams and KAMs, and healthcare customers. What does a best-in-class value communication tool look like in 2022? What are the key considerations when…

1
افیلیت مارکتینگ چیست؟ (Affiliate Marketing) / مهم ترین مهارت اجتماعی - قسمت دوم 35:11

2y ago35:11

35:11

تو قسمت موفقیت این اپیزود, میخوایم در مورد ۴ تا از اشتباه های رایج مکالمه هامون صحبت کنیم، این که چرا این اشتباه ها رو انجام میدیم، چجوری اتفاق میوفتن و چی هستن اصلا این اشتباه ها. تو بخش آخر هم سعی میکنیم چند تا راه حل عملی واسه کم شدن این اشتباه ها بگیم. و تو قسمت تکنولوژی هم در مورد affiliate marketing صحبت میکنیم که یک طرح کسب و کار جالب و آیند…

1
(چت بات چیه ؟ ‏ / مهم ترین مهارت اجتماعی (قسمت اول (Chatbot) 32:35

2y ago32:35

32:35

چرا از چت بات استفاده بکنیم؟-چون سرعت میره بالا-هزینه ها پایین میاد-یک کارمند ۲۴ ساعته آماده پاسخویی دارین-آمارنشون میده مشتری ها نسبتا کار باهاش رو دوس دارن-ساختنش راحته و احتیاج به دونستن زبون برنامه نویسی ندارهچت بات چیه و چطوری کار میکنه؟-امیر توضیح میده چجوری و کجا ها چت بات ها به درد میخورن مثل سایت هایی که با کاربر زیاد سر و کار دارن و میخوا…

1
Population to Person: How will the NHS translate population health management into impactful, person-centred service change? 56:04

2y ago56:04

56:04

What does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health management into impactful service change and what will this look like for patients? Tom Clarke (Director, Mtech Access) explores all this and more with guest speaker Dr Steven Laitner (GP, Parkbury House Surgery). St…

1
نتورکینگ(Networking) چیه و چجوریه؟ اپلیکیشن کلاب هوس (Clubhouse) چیه؟ 38:11

2y ago38:11

38:11

تو این اپیزود میگیم چرا، چجوری نتورک کنیم و محصول نتورک کردن چیه؟ تو قسمت چرا، علی توضیح میده نتورک فقط برای کار نیست و‌ برای تبادل اطلاعات تو زمینه علاقه هامون هم میتونیم ارتباط برقرار کنیم با آدم ها و تاثیر خوبشو تو زندگیمون ببینیم. تو قسمت چجوری، امیر اومده که اپلیکیشن کلاب هوس رو معرفی کنه که جدید هم هست و‌ جای مناسبیه واسه پیدا کردن آدم های هم…

1
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges? 59:25

2y ago59:25

59:25

What does the ‘2022/23 priorities and operational planning guidance’ document mean for the NHS, for Integrated Care System (ICS) development and for an NHS workforce still battling COVID? How realistic and achievable are the priorities set out, and how can Pharma and Medtech best help NHS leaders to achieve these goals? Caroline Dawe (Deputy Direct…

1
(هرم موفقیت)‎چجوری مداومت داشته باشیم؟ /(Elsa)‎اپلیکیشن السا برای مکالمه زبان انگلیسی 40:19

2+ y ago40:19

40:19

یکی از چالش های شروع هر کاری که میخوایم از اون نتیجه بگیریم،تداوم یا ادامه دادنه. -این که بتونیم تو مسیر بمونیم،مخصوصا اوایل تو قدم های اول که نتیجه ای در کار نیست. -تو این قسمت با یک راه حل تست شدهتوسط آدمای موفق اومدیم به اسم هرم موفقیت. -با این روش شما میتونین تقریبا تو هر پروژه ای تداوم داشته باشید و به موفقیت برسید. -تو قسمت تکنولوژی پادکست، ا…

1
The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion 1:02:57

2+ y ago1:02:57

1:02:57

Pharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how Pharma and Medtech can best support the NHS in 2022. We were joined by some of Mtech Access’s closest and most insightful friends: - David Thorne (Director, Mtech Acc…

1
چرا پادکست میسازیم؟ گوگل داکس چیست؟ 1:11:37

2+ y ago1:11:37

1:11:37

ما که نه اسپانسری داریم نه درامد مستقیمی از این پادکست، پس چرا این پادکست رو میسازیم؟ - هدف اصلیمون لذت بردنه -هدف بعدی یادگیریه. یادگیری مهارت هایی ک تو مسیر پادکست ساختن لازم داریم -هدف سوم اضافه کردن ارزش به بقیه که بتونن زندگی خودشون رو رشد بدن -هدف چهارم هم پیدا کردن مخاطب‌های جدید و دوستی و کار و رابطه باهاشونه ک این اون قسمتی ک میتونه از نظر…

1
Optimising the NHS – How will medicines be valued in integrated systems? 54:03

2+ y ago54:03

54:03

How will medicines be valued in the newly integrated world of the NHS? What are the risks and benefits of a single national formulary? What else is changing? And what does this mean for market access? Ellen Rule (Programme Director of the Gloucestershire Integrated Care System [ICS] and Director of Transformation and Service Redesign, Gloucestershi…

1
Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe 1:00:49

2+ y ago1:00:49

1:00:49

We explore the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are faced with a complex, ever-changing market landscape. These treatments also face unique tactical challenges on the route to securing market access. Here we bring …

1
A new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales) 59:33

2+ y ago59:33

59:33

How are healthcare systems looking differently at their population to deliver better care and what does this mean for future decision-making? How might the NHS re-imagine the hospital? What benefits can we expect from novel technologies, and can the NHS develop system resilience to improve healthcare outcomes? Dr Phil Webb (Chief Executive of Respi…

1
Innovations to address health inequalities in the NHS and how Pharma and Medtech can help 59:29

2+ y ago59:29

59:29

How can the NHS address health inequalities through innovation? How can new health technologies help improve population health? How can Pharma, Medtech and the wider life sciences industry support the NHS with these goals? And what does the NHS’ ambitions in this area mean for your market access strategy? Jon Siddall (Chief Executive of the South W…

Podcasty warte posłuchania

MTech Podcasty

Podcasty warte posłuchania

Skrócona instrukcja obsługi